Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

400 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
18F-labeled tracers targeting fibroblast activation protein.
Lindner T, Altmann A, Giesel F, Kratochwil C, Kleist C, Krämer S, Mier W, Cardinale J, Kauczor HU, Jäger D, Debus J, Haberkorn U. Lindner T, et al. EJNMMI Radiopharm Chem. 2021 Aug 21;6(1):26. doi: 10.1186/s41181-021-00144-x. EJNMMI Radiopharm Chem. 2021. PMID: 34417894 Free PMC article.
Targeting of activated fibroblasts for imaging and therapy.
Lindner T, Loktev A, Giesel F, Kratochwil C, Altmann A, Haberkorn U. Lindner T, et al. EJNMMI Radiopharm Chem. 2019 Jul 25;4(1):16. doi: 10.1186/s41181-019-0069-0. EJNMMI Radiopharm Chem. 2019. PMID: 31659499 Free PMC article. Review.
Impact of Primary Staging with Fibroblast Activation Protein Specific Enzyme Inhibitor (FAPI)-PET/CT on Radio-Oncologic Treatment Planning of Patients with Esophageal Cancer.
Ristau J, Giesel FL, Haefner MF, Staudinger F, Lindner T, Merkel A, Schlittenhardt J, Kratochwil C, Choyke PL, Herfarth K, Debus J, Haberkorn U, Koerber SA. Ristau J, et al. Among authors: lindner t. Mol Imaging Biol. 2020 Dec;22(6):1495-1500. doi: 10.1007/s11307-020-01548-y. Epub 2020 Oct 15. Mol Imaging Biol. 2020. PMID: 33063132 Free PMC article.
FAP imaging in rare cancer entities-first clinical experience in a broad spectrum of malignancies.
Dendl K, Finck R, Giesel FL, Kratochwil C, Lindner T, Mier W, Cardinale J, Kesch C, Röhrich M, Rathke H, Gampp H, Ristau J, Adeberg S, Jäger D, Debus J, Haberkorn U, Koerber SA. Dendl K, et al. Among authors: lindner t. Eur J Nucl Med Mol Imaging. 2022 Jan;49(2):721-731. doi: 10.1007/s00259-021-05488-9. Epub 2021 Aug 3. Eur J Nucl Med Mol Imaging. 2022. PMID: 34342669 Free PMC article.
A Tumor-Imaging Method Targeting Cancer-Associated Fibroblasts.
Loktev A, Lindner T, Mier W, Debus J, Altmann A, Jäger D, Giesel F, Kratochwil C, Barthe P, Roumestand C, Haberkorn U. Loktev A, et al. Among authors: lindner t. J Nucl Med. 2018 Sep;59(9):1423-1429. doi: 10.2967/jnumed.118.210435. Epub 2018 Apr 6. J Nucl Med. 2018. PMID: 29626120 Free PMC article.
68Ga-FAPI PET/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers.
Giesel FL, Kratochwil C, Lindner T, Marschalek MM, Loktev A, Lehnert W, Debus J, Jäger D, Flechsig P, Altmann A, Mier W, Haberkorn U. Giesel FL, et al. Among authors: lindner t. J Nucl Med. 2019 Mar;60(3):386-392. doi: 10.2967/jnumed.118.215913. Epub 2018 Aug 2. J Nucl Med. 2019. PMID: 30072500 Free PMC article.
PET/CT Imaging of NSCLC with a αvβ6 Integrin-Targeting Peptide.
Flechsig P, Lindner T, Loktev A, Roesch S, Mier W, Sauter M, Meister M, Herold-Mende C, Haberkorn U, Altmann A. Flechsig P, et al. Among authors: lindner t. Mol Imaging Biol. 2019 Oct;21(5):973-983. doi: 10.1007/s11307-018-1296-6. Mol Imaging Biol. 2019. PMID: 30671741
400 results